Codes / ICD10CM / M10.279

M10.279 Drug-induced gout, unspecified ankle and foot

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Common Name: Drug-induced gout, unspecified ankle and foot
  • Technical Term: Drug-induced gout, unspecified ankle and foot

Summary

Drug-induced gout is a form of inflammatory arthritis caused by medications that elevate uric acid levels, leading to urate crystal deposition in joints. This condition specifically affects the ankle and foot joints, resulting in acute inflammation and pain.

Causes

This condition arises from medications that increase uric acid production or reduce its excretion. Common triggers include diuretics, immunosuppressants, low-dose aspirin, and certain chemotherapy agents. The elevated uric acid promotes crystal formation in synovial fluid, triggering an inflammatory response in the ankle and foot joints.

Risk Factors

  • Use of medications known to raise uric acid levels
  • Pre-existing hyperuricemia or gout history
  • Renal impairment (reduced uric acid excretion)
  • Dehydration or high-purine diets (exacerbating uric acid buildup)

Symptoms

  • Sudden, severe joint pain (often nocturnal)
  • Swelling, redness, and warmth in affected joints
  • Limited range of motion
  • Tenderness to touch
  • Fever (in severe cases)

Diagnosis

Diagnosis involves a physical exam of inflamed joints, blood tests for uric acid levels, and joint fluid analysis to detect urate crystals. Imaging (e.g., X-rays, ultrasound) may assess joint damage, while medication history confirms the drug-induced etiology.

Treatment Options

Treatment focuses on relieving acute symptoms and addressing the underlying cause. Nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, or corticosteroids may reduce inflammation. Discontinuing the offending medication, if possible, is critical. Long-term management may include uric acid-lowering therapies.

Prognosis and Follow-Up

With appropriate treatment, symptoms often resolve within days to weeks. However, recurrent episodes or persistent hyperuricemia may require ongoing management. Follow-up monitoring of uric acid levels and joint function is recommended to prevent complications.

Complications

Untreated or recurrent drug-induced gout can lead to chronic joint damage, tophi (urate crystal deposits), or kidney stones. Persistent inflammation may also increase the risk of osteoarthritis in affected joints.

Lifestyle & Prevention

  • Avoid or limit use of medications known to raise uric acid levels when possible.
  • Maintain hydration to support uric acid excretion.
  • Follow a low-purine diet to reduce uric acid production.
  • Monitor uric acid levels regularly if on high-risk medications.

When to Seek Professional Help

Seek medical attention if you experience sudden, severe joint pain, swelling, or redness, especially if you are taking medications known to affect uric acid levels. Prompt evaluation is important to confirm the diagnosis and initiate treatment.

Tips for Medical Coders

Document the specific ankle and foot involvement as "unspecified" when the exact site is not documented. Ensure the medication history is clearly recorded to support the drug-induced etiology. Code M10.279 is appropriate when the condition affects the ankle and foot without further specification.

Book a walkthrough

M10.279 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.